Inspection IDReason for InspectionInspection DateInspection Status 
SIN-00266708 Renewal 05/20/2025 Compliant - Finalized
RegulationLIS Non-Compliance AreaCorrection RequiredPlans of CorrectionCorrection DatePOC Status
6500.24(e)(3)The agency is Individual #1's acting representative payee. Individual #1's current assessment, completed on 11/1/24, indicates that Individual #1 requires "reminders" to "manage spending money," and to "perform cash transactions, including waiting for change." Individual #1's Individual Support Plan, last updated 4/3/25, explains that "[Individual #1] is unable to manage [their] personal finances." On 5/21/25, Individual #1's May 2025 financial ledger in the home documented that the following purchase greater than $15 was made on Individual #1's behalf without documentation of a receipt: On 5/6/25, Walmart, totaling $28.42.If the agency or family assumes the responsibility for an individual's financial resources, the following shall be maintained: documentation, by actual receipt or expense record, of each single purchase exceeding $15 made on behalf of the individual carried out by family members or agency staff.The receipt was located and attached to the expenditure sheet to meet compliance. The expense sheet will be shared in a separate email for proof. 06/09/2025 Implemented
6500.121(c)(9)Individual #1's date-of-birth is 12/4/63. Individual #1 had prostate examinations via prostate-specific antigen blood tests completed on 4/23/24, and then again on 5/13/25. The physical examination shall include: A prostate examination for men 40 years of age or older.Individual #1's most recent prostate exam was completed on 5/13/2025. Individual #1's Program Specialist will ensure that the next prostate examination via prostate-specific antigen blood test will be completed prior to 5/13/2026. 06/09/2025 Implemented
6500.152(c)Individual #1's Individual Support Plan, last updated 4/3/25, stated that "[Individual #1] is aware of basic safety rules···heat sources are not safety issues." However, Individual #1's assessment, completed on 11/1/24, indicated that a "Reminder [is] needed [for] [Individual #1] to remain safe around non-insulated heat sources."; and regarding supervision needs within the home, Individual #1's Individual Support Plan, last updated 4/3/25, explained that "[Individual #1] should be supervised at all times at home. [They] [are] able to be left alone in [their] room with periodic checks." In contrast, Individual #1's assessment, completed on 11/1/24, informed that Individual #1 requires no supervision when "inside the home in general" and when "inside the home's bathroom."The individual plan shall be initially developed, revised annually and revised when an individual's needs change based upon a current assessment.On 6/4/2025 Individual #1's assessment was updated to reflect that the individual is safe around non-insulated heat sources. On 6/4/2025 Individual #1's assessment was updated to reflect the ISP that the individual is hearing distance inside the home with periodic checks. This also reflects that the individual is hearing distance while using the restroom. 06/09/2025 Implemented
SIN-00192363 Renewal 08/31/2021 Compliant - Finalized
RegulationLIS Non-Compliance AreaCorrection RequiredPlans of CorrectionCorrection DatePOC Status
6500.136(a)(10)Individual #1 is prescribed Alendronate Sodium 70 mg tablet- Take 1 tablet by mouth on an empty stomach once a week (do not lie down, eat or drink for 30 minutes). The August 2021 medication administration record does not indicate the time for which the medication is to be administered. The medication was administered on 08/01/21, 08/08/21, 08/15/21, 08/22/21, and 08/29/21.A medication record shall be kept, including the following for each individual for whom a prescription medication is administered: Administration times.Medication Administration Record will be fixed to include this medications administration time. This will be documented each month moving forward to maintain compliance. 09/23/2021 Implemented
6500.136(a)(11)The August 2021 Medication Administration Record for Individual #1 does not include a diagnosis or purpose for the following prescribed medications: Fluvoxamine Maleate ER 24 hr., 100 Mg Cap Par (Take two capsules by mouth once daily. Do not crush. Take whole); Levetiracetam, 1000mg (Take one tablet---1000 mg---by mouth two times a day); Nexium, 20 mg (Take two capsules by mouth daily at 8 am. Swallow whole); Olanzapine, 5 mg (Take one tablet by mouth every day at 4 pm); Vitamin C, 500 mg (Take two tablets by mouth once daily. Do not lie down for at least 30 minutes after taking this medication. Drink plenty of water while taking); Olanzapine, 10 mg (Take one tablet by mouth daily); Vitamin D3, 500 unit cap (Take two capsules by mouth daily); Alendronate Sodium, 70 mg Tab Cipl (Take one tablet by mouth on an empty stomach once a week. Do not lie down, eat, or drink after taking medication for 30 minutes), and Erythromycin OP, 5 mg/ gm ointment---Apply ½ inch ribbon (Apply ½ inch ribbon in left eye socket every 4 hours while awake for 2 days. Use only when needed as directed).A medication record shall be kept, including the following for each individual for whom a prescription medication is administered: Diagnosis or purpose for the medication, including pro re nata.Individuals Prescribing physicians will be contacted to clarify prescribing diagnosis's for individuals medications. This information will be communicated with the individuals pharmacy and Medication Administration Records will be updated to include diagnosis or purpose of the prescribed medication. 10/01/2021 Implemented
SIN-00227613 Renewal 07/12/2023 Compliant - Finalized
SIN-00176686 Renewal 09/22/2020 Compliant - Finalized
SIN-00113955 Renewal 05/03/2017 Compliant - Finalized
SIN-00077446 Renewal 04/09/2015 Compliant - Finalized
SIN-00062486 Renewal 04/08/2014 Compliant - Finalized